ACTIVE PHARMACEUTICAL INGREDIENTS

SR.NO PRODUCT NAME CAS NO. DMF NO.
1 ANTI-CANCER
Bendamustine Hydrochloride Monohydrate 1374784-02-7 27272
Cyclophosphamide Monohydrate ^ # 6055-19-2
Carmustine^ 154-93-8 30492
Melphalan Hydrochloride 3223-07-2 29766
Melphalan # 148-82-3
2 RARE DRUGS
Carglumic Acid * 1188-38-1 33132
Fomepizole 7554-65-6 19683
Trientine Hydrochloride USP* 38260-01-4 030905
3 PHOSPHATE BINDERS
Sevelamer Carbonate 845273-93-0 27405
Sevelamer Hydrochloride 152751-57-0 27908
Sucroferric Oxyhydroxide ^ # 12134-57-5
4 HAEMATOLOGICALS
Argatroban USP 141396-28-3
Iron Sucrose Complex USP 8047-67-4 18261
Phytonadione (Vitamin K1) -Oral Grade 84-80-0 030910
Phytonadione (Vitamin K1) -Injectable grade ^ 84-80-0
Sodium Ferric Gluconate Complex ^# 34089-81-1
5 CARDIOVASCULAR
Colestipol Hydrochloride *# 37296-80-3
Colesevelam Hydrochloride # 182815-44-7
Hydralazine Hydrochloride USP 304-20-1 024321
Nicardipine Hydrochloride USP 54527-84-3 19773
Phenoxybenzamine HCl USP 63-92-3 031746
6 ANTI-RHEUMATIC
Penicillamine ^ 52-67-5 33106
7 CNS
Benztropine Mesylate USP 132-17-1 32136
Asenapine Maleate # 85650-56-2
Fosaprepitant Dimeglumine 265721-04-8 33105
8 ANESTHETICS
Ropivacaine Hydrochloride 132112-35-7 30152
Ropivacaine 84057-95-4 19084

NOTE:

  • All products marked * are under exclusivity for BOTH, the US & Europe market.
  • All products marked ^ are under exclusivity for the US market.
  • All products marked # are under validation & will be available shortly for commercial supply.

Patented products are available for R&D purposes only as permitted under 35 U.S.C. Section 271 (e) (I).